Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CollPlant Biotechnologies (CLGN) Interest & Investment Income (2020 - 2025)

CollPlant Biotechnologies filings provide 5 years of Interest & Investment Income readings, the most recent being $329000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 71.35% to $329000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $741000.0, a 39.06% decrease, with the full-year FY2025 number at $380000.0, down 48.51% from a year prior.
  • Interest & Investment Income hit $329000.0 in Q4 2025 for CollPlant Biotechnologies, up from $24000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $674000.0 in Q4 2023 to a low of $24000.0 in Q3 2025.
  • Median Interest & Investment Income over the past 4 years was $196000.0 (2025), compared with a mean of $232000.0.
  • The widest YoY moves for Interest & Investment Income: up 71.35% in 2025, down 88.89% in 2025.
  • CollPlant Biotechnologies' Interest & Investment Income stood at $98000.0 in 2021, then surged by 587.76% to $674000.0 in 2023, then crashed by 71.51% to $192000.0 in 2024, then surged by 71.35% to $329000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $329000.0 (Q4 2025), $24000.0 (Q3 2025), and $196000.0 (Q1 2025) per Business Quant data.